Document is current

Any future updates will be listed below

Effects of the ghrelin receptor agonist anamorelin on lean body mass in cancer patients with cachexia; results from a Phase II randomized, double blind, multicenter study

Crossref DOI link: https://doi.org/10.1186/2049-3002-2-S1-P19

Published Online: 2014-05-28

Published Print: 2014-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark